Genotyping Assay Market Report Examines Leading Companies And Growth Opportunities

The genotyping assay market is rapidly emerging as a pivotal sector within biotechnology, driven by advances in genetic analysis and personalized medicine. As research and clinical applications grow more sophisticated, this industry is expected to experience substantial growth. Below, we explore the market's projected size, leading players, influential trends, and the key segments shaping its future.

Projected Market Size and Growth Trajectory of the Genotyping Assay Market
The genotyping assay market is forecasted to expand dramatically, reaching a value of $116.09 billion by 2030. This represents an impressive compound annual growth rate (CAGR) of 22.9%. The anticipated growth stems from various factors, including the rise in biomarker-driven drug development, increasing automation within laboratories, the broadening scope of companion diagnostics, heightened demand for rapid assay results, and stringent regulatory validation processes. Noteworthy trends influencing this market include a growing preference for SNP-based assays, wider adoption of PCR-based genotyping techniques, advancements in highly sensitive genotyping assays, greater utilization in drug development, and enhanced integration of automation during assay processing.

The genotyping assay market size has grown exponentially in recent years. It will grow from $41.31 billion in 2025 to $50.86 billion in 2026 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to development of pcr techniques, growth of molecular diagnostics, pharmaceutical safety testing needs, early assay commercialization, academic research demand.

Download a free sample of the genotyping assay market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Key Companies Dominating the Genotyping Assay Industry
The genotyping assay sector features several major industry players, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies plc, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., and New England Biolabs.
In a recent development, August 2023 saw US-based biotechnology firm Transnetyx Inc. acquire Laragen Inc. for an undisclosed amount. This strategic move aims to expand Transnetyx's service portfolio by adding sequencing and next-generation sequencing (NGS) capabilities, thereby providing research institutions with enhanced access to advanced genetic testing. Laragen Inc., also US-based, specializes in sequencing and genotyping assay services for DNA.

Emerging Trends Transforming the Genotyping Assay Sector
Leading companies in the genotyping assay market are focusing on breakthroughs in genomic research, such as developing CE-IVD marked assays to detect drug-resistant HIV-1 strains. For example, Thermo Fisher Scientific introduced the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit in January 2023. This assay, based on Sanger sequencing technology, identifies genetic variants in HIV samples that cause resistance to antiretroviral treatments. Designed for clinical applications, it offers features such as detecting drug resistance mutations using HIV RNA, providing ready-to-use reagents and controls, and compatibility with current sequencing workflows. Its launch has enhanced the ability to accurately detect treatment-resistant HIV strains and supports regulatory compliance.

View the full genotyping assay market report:
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Breakdown of Segments Covered in the Genotyping Assay Market Report
The genotyping assay market analysis is segmented into the following categories:
1) Product and Service: including Reagents and Kits, Genotyping Services, Instruments, and Bioinformatics tools
2) Technology: encompassing Microarrays, Polymerase Chain Reaction (PCR), Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption or Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS), and other relevant technologies
3) End-User: covering Pharmacogenomics, Personalized Medicine and Diagnostics, Animal Genetics, Agricultural Biotechnology, Research and Diagnostic Laboratories, and Academic Institutions
Additional subcategories include:
- Reagents and Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits
- Genotyping Services: services like Genotyping by PCR, Whole Genome Sequencing, and SNP Genotyping
- Instruments: including PCR Machines, Sequencing Machines, and Microarrays
- Bioinformatics: comprising Data Analysis Software and Genotyping Data Management Tools

This comprehensive segmentation provides insight into the diverse components and applications that are propelling the genotyping assay market forward.

New analytical features added to our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.